U023 Knowing Lichenoid Dermatoses: Common Pathways and Treatments
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Lichenoid dermatoses include a broad spectrum of diseases with overlapping clinical and histological features. However, it remains unclear whether distinct lichenoid dermatoses such as lichen planus and lichen planopilaris share a common immunopathogenesis. This session will provide a cutting-edge overview on the immunopathogenesis of lichenoid dermatoses with particular emphasis on lichen planus, lichen planopilaris and lichen planus pigmentosus. The session will highlight recent advances in our understanding of these related lichenoid as systemic diseases and discuss their associated comorbidities. Finally, this session will discuss current and emerging therapeutic options for the practicing dermatologist.
LEARNING OBJECTIVES
Summarize the current evidence for distinct and shared pathogenesis mechanisms of lichenoid dermatoses.
Recognize that lichen planus and lichen planopilaris are systemic diseases with associated comorbidities.
Discuss new upcoming treatments for lichen planus, lichen planopilaris and lichen planus pigmentosus.
SCHEDULE
12:30 AM
Immunopathogenesis of lichenoid dermatoses: continuation on a spectrum?
Matthew Vesely, MD, PhD, FAAD
12:45 AM
Lichen planus and lichen planopilaris as systemic diseases
Jeffrey Marcus Cohen, MD, FAAD
1:00 AM
Lichen planopilaris and Lichen planus pigmentosus: current and emerging therapies
Crystal Aguh, MD, FAAD
1:15 AM
Q&A session
SPEAKERS
Crystal Aguh, MD, FAAD
Jeffrey Marcus Cohen, MD, FAAD
Matthew Vesely, MD, PhD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Crystal Aguh, MD, FAAD
Eli Lilly and Company – Consultant(Fees); Myovant Sciences – Advisory Board(Fees); Olaplex – Advisory Board(Fees); Pfizer Inc. – Consultant(Fees); UpToDate, Inc – Other(Fees);
Jeffrey Marcus Cohen, MD, FAAD
Advarra – Data Safety Monitoring Board(Fees); Logical Images, Inc – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees);
Matthew Vesely, MD, PhD, FAAD
Almirall – Advisory Board(Fees); Regeneron – Employee(Salary);